(MedPage Today) — A dexamethasone-sparing regimen involving lenalidomide (Revlimid) and the anti-CD38 drug daratumumab (Darzalex) was safe and effective in older, frail patients with newly diagnosed multiple myeloma, according to a randomized…
Source link : https://www.medpagetoday.com/hematologyoncology/myeloma/117821
Author :
Publish date : 2025-10-06 21:03:00
Copyright for syndicated content belongs to the linked Source.
